Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2017.6247 mmr-15-04-2313 Articles Mutational spectrum of CENP-B box and α-satellite DNA on chromosome 21 in Down syndrome children ChenQian 1 * TanBin 2 * HeJun-Lin 3 LiuXue-Qing 3 ChenXue-Mei 3 GaoRu-Fei 3 ZhuJing 2 WangYing-Xiong 3 * QiHong-Bo 1 * Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China Pediatrics Research Institute, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 400014, P.R. China Laboratory of Reproductive Biology, Public Health College, Chongqing Medical University, Chongqing 400016, P.R. China Correspondence to: Dr Hong-Bo Qi, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing 400016, P.R. China, E-mail: qihongbo_cqmu@yahoo.com Professor Ying-Xiong Wang, Laboratory of Reproductive Biology, Public Health College, Chongqing Medical University, 1 Yixueyuan Road, Chongqing 400016, P.R. China, E-mail: wangyingxiong@yahoo.com

Contributed equally

 032017 24022017 15 4 2313 2317 16122015 13012017 Copyright © 2017, Spandidos Publications 2017

The centromere is responsible for the correct inheritance of eukaryotic chromosomes during cell division. Centromere protein B (CENP-B) and its 17 base pair binding site (CENP-B box), which appears at regular intervals in centromeric α-satellite DNA (α-satDNA), are important for the assembly of the centromere components. Therefore, it is conceivable that CENP-B box mutations may induce errors in cell division. However, the association between the deoxynucleotide alterations of the CENP-B box and the extra chromosome 21 (Chr21) present in patients with Down syndrome (DS) remains to be elucidated. The mutational spectrum of the α-satDNA, including 4 functional CENP-B boxes in Chr21 from 127 DS and 100 healthy children were analyzed by direct sequencing. The de novo occurrences of mutations within CENP-B boxes in patients with DS were excluded. The prevalence of 6 novel mutations (g.661delC, g.1035_1036insA, g.1076_1077insC, g.670T>G, g.1239A>T, g.1343T>C) and 3 single nucleotide polymorphisms (g.727C/T, g.863A/C, g.1264C/G) were not significantly different between DS and controls (P>0.05). However, g.525C/G (P=0.01), g.601T/C (P=0.00000002), g.1279A/G (P=0.002), g.1294C/T (P=0.0006) and g.1302 G/T (P=0.004) were significantly associated with the prevalence of DS (P<0.05). The results indicated that CENP-B boxes are highly conserved in DS patients and may not be responsible for Chr21 nondisjunction events. However, α-satDNA in Chr21 is variable and deoxynucleotide deletions, mutations and polymorphisms may act as potential molecular diagnostic markers of DS.

 Down syndrome mutation centromere protein B box α-satellite DNA Introduction

Down syndrome (DS), or trisomy 21, results from the presence of all or part of an extra chromosome (Chr) 21 and is a high-incidence birth defect that is often associated with physical disorders (1–3) that have no explicit mechanism. Incorrect partitioning of sister chromatids to the daughter cells may induce aneuploidy, including trisomy 21 (4,5). Centromeres, the evident structures that are located in the center of chromosomes are responsible for chromosome segregation. A previous study indicated that the highly conserved centromere protein B (CENP-B) and its 17 base pair (bp) binding site (CENP-B box) are required for de novo mammalian artificial chromosome formation (6). In vivo analyses with cultured human cells suggested that the presence of the CENP-B box is essential for the formation of functional centromere components (7,8). In addition, CENP-B binding to the CENP-B boxes influences nucleosome positioning in centromeric regions and this binding is required for accurate chromosome segregation (9–11). Therefore, this suggests that nondisjunction of Chr21 may be induced by a defective functioning of the centromere with a CENP-B box mutation.

To determine whether the mutation or absence of the CENP-B box is involved with extra Chr21 formation in DS, the CENP-B boxes in Chr21 α-satellite DNA (α-satDNA) of 127 DS children were investigated using polymerase chain reaction (PCR) and direct sequencing. The observations of the present study provide an insight into the molecular association between the CENP-B box and α-satDNA in Chr21, which may be a major contributor to the occurrence of trisomy 21.

 Materials and methods <sec> <title>Patient recruitment

A total of 127 Chinese children with DS were recruited from the Children's Hospital of Chongqing Medical University (Chongqing, China). Cytogenetic analysis demonstrated the karyotypes were 47, XY, +21 or 47, XX, +21 in all the patients. In addition, 100 healthy children with normal karyotypes were also enrolled as the control group. The distribution of age and residential placement did not differ between controls and DS patients. Peripheral blood samples were collected from all participants. The study was approved by the Ethics Committee of Chongqing Medical University. Informed consent was obtained from all individual participants included in the study.

 PCR amplification and sequencing

Genomic DNA was extracted from peripheral blood samples with TIANamp Blood DNA kit (Tiangen Biotech Co., Ltd., Beijing, China). α-satDNA (GenBank accession no. D29750.1) in the centromeric region of Chr21 was amplified as two overlapping fragments, with each fragment containing two CENP-B boxes (Fig. 1). Oligonucleotide primer sequences were as follows: α-satellite part A, forward 5′-GGAATATCGTCATACAAAAT-3′, reverse 5′-TATCAATGGCAAAGTTCA-3′; and α-satellite part B, forward 5′-GTTGAACTTTGCCATTGA-3′, and reverse, 5′-GCTCTAAGAAAGCGAATG-3′. PCR was performed using the Takara Taq™ PCR kit (Takara Biotechnology, Co., Ltd., Dalian, China), according to the manufacturer's protocol, using 200 ng genomic DNA and 20 nM primers (1 µl). PCR thermocycling conditions were as follows: 94°C for 4 min (initial denaturation), followed by 30 cycles at 95°C for 30 sec (denaturation), 46°C/43°C for 30 sec (primer annealing) for part A/B, respectively, and 72°C for 45 sec (PCR product elongation), a final extension step was at 72°C for 5 min. PCR products were run on 1.5% agarose gels to detect possible large sequence rearrangements. Following the removal of unincorporated primers and excess dNTPs by exonuclease I and shrimp alkaline phosphatase, the amplified fragments were directly sequenced on an ABI-3100 Genetic Analyzer (Applied Biosystems; Thermo Fisher Scientific, Inc., Waltham, MA, USA). Each sample was compared with NCBI RefSeq sequence of α-satDNA.

 Statistical analysis

Statistical analysis was used to summarize the clinical characteristics of the subjects. Associations between polymorphisms of DS and control group were examined using the Chi-square test. P<0.05 was considered to indicate a statistically significant difference. All data were analyzed using SPSS software, version 16.0 (SPSS, Inc., Chicago, IL, USA).

 Results <sec> <title>Gel electrophoresis

The gel electrophoresis indicated that the 773 and 535 bp PCR fragments from α-satDNA were amplified correctly. There was no observation of a mispairing present in the agarose gels. There was no visible difference in gel electrophoresis between amplified fragments of DS and healthy children (Fig. 2). To examine whether the two fragments exhibited a point mutation, direct sequencing was performed following gel electrophoresis.

 CENP-B boxes in Chr21 are highly conserved

The affected patients with DS and healthy children underwent DNA analysis by sequencing of PCR products, of four CENP-B boxes that are respectively located at the g.493_509, g.835_851, g.1173_1189 and g.1511_1527 sites of α-satDNA in Chr21. No mutation or absence of CENP-B boxes in the 127 patients with DS and 100 healthy children was observed. All four CENP-B boxes in Chr21 were demonstrated to be highly conserved (Fig. 3).

 α-satDNA sequence is highly variable

The direct sequencing of α-satDNA indicated numerous underlying nucleotide alterations. The variations were point nucleotide deletions, substitutions, insertions and polymorphisms. The novel identified mutations were as follows: g.661delC, g.670T>G, g.1239A>T, g.1343T>C, g.1035_1036insA and g.1076_1077insC (Fig. 4). All the mutations were observed to be present in DS and control groups, however statistical analysis suggested that there was no significant difference between their occurrence in the two groups (P>0.05; Table I). Furthermore, 8 polymorphism sites were observed in the majority of samples and to the best of our knowledge, these had not previously been reported. However, occurrence of the g.525C/G (P=0.01), g.601T/C (P=0.00000002), g.1279A/G (P=0.002), g.1294C/T (P=0.0006) and g.1302 G/T (P=0.004) sites in the DS group demonstrated a significant difference compared with the control group (P<0.05) However, no differences in g.727C/T (P=0.36), g.863A/C (P=0.207) and g.1264C/G (P=0.073) sites were observed between the two groups (Fig. 5; Table I).

 Discussion

DS is a common chromosomal disorder in human aneuploidy, and a termination of pregnancy occurs for the majority DS fetuses identified via Down's screening and amniocentesis. The extra Chr21 results from a meiotic nondisjunction event, with 88% from nondisjunction in the maternal gamete and 8% in the paternal gamete. But the underlying molecular genetics mechanism linking nondisjunction to Chr21 remains to be fully elucidated. Therefore, it is necessary to determine the genotypes of DS to provide a methodology for antenatal examination and gene diagnosis for trisomy 21 in noninvasive prenatal testing.

The current study identified that the CENP-B boxes are highly conserved in DS and healthy children. Human Chr21 contains a large repetitive sequence and consists of 11 tandem repeats of an AT-rich 171 bp alphoid monomer unit. This 11mer repeat construct is a 1.3 Mbp higher order α-satDNA repeat on the centromeric area. Each monomer has a unique 17 bp sequence, however only five have the CENP-B binding activity known as the CENP-B box (12,13). In the human artificial chromosome (HAC), CENP-B box mutations induced no HAC formation and diminution of CENP-A assembly (6,11,14). CpG methylation and point mutation of the CENP-B box reduced CENP-B binding activity (15–17). Therefore, the CENP-B box is required for de novo centromere chromatin assembly on human α-satDNA. The present study identified the methylation status of CpG dinucleotides in CG islands; however, the results did not show any difference in the DNA methylation status between DS and healthy people as previously described (18).

A cohort of 127 patients diagnosed with DS and 100 healthy children in Chongqing were investigated via chromosome screening. The spectrum of α-satDNA variants in Chr21 was analyzed by direct DNA sequencing. The present study identified 14 novel variations that, to the best of our knowledge, have not previously been reported. A total of 6 mutations were identified in the Chinese population: g.661delC, g.670T>G, g.1239A>T, g.1343T>C, g.1035_1036insA and g.1076_1077insC. The present study revealed the distribution and frequency of novel variations among the population in Chongqing. For human Chr21, α-satDNA appears to be the major constituent of functional centromeres (19), as it is associated with the existence of functional centromere components on the endogenous human chromosome and the ability to induce de novo centromere assembly. In the present study, the CENP-B box and α-satDNA sequence were required for de novo mammalian artificial chromosome formation and assembly of functional centromere components, including CENP-A, CENP-C, and CENP-E (20,21). These results demonstrated the presence of a variable in α-satDNA, other than the CENP-B box, which may be important for de novo centromere formation function (8,16,22,23). In addition, the present study reported eight single nucleotide polymorphisms (SNPs) of α-satDNA in Chr21. Three SNPs, including g.727C/T, g.863A/C and g.1264C/G did not demonstrate any difference in occurrence between DS and healthy children. It was therefore hypothesized that the variants identified in the present study may be due to ethnic disparities, as suggested by previous studies (18,24) and consequently, these variants may act as DNA markers for distinguishing ethnicities. However, five SNPs including g.525C/G, g.601T/C, g.1279A/G, g.1294C/T and g.1302 G/T were observed to be significantly different between the DS and control group, and may therefore act as potential molecular diagnostic markers of DS.

The present study exhibited various limitations. Firstly, the study was conducted on a small sample size and larger sample sizes are required to confirm these associations in the future. Furthermore, the patients were from the same region of China, therefore further studies should include individuals from different regions of China and of different ethnicities.

In conclusion, the present study investigated the α-satDNA variants present in Chr21 and any differences in genotype between DS and healthy children. The results demonstrated that CENP-B box mutations were not present and the box appears to be highly conserved in DS patients and therefore may not be responsible for Chr21 nondisjunction events. Furthermore, 14 novel variations were identified in this investigation and the differing mutation spectrum of α-satDNA between DS and healthy individuals may contribute to complex DS phenotypes and act as potential dinucleotide markers for diagnosing trisomy 21.

 Acknowledgements

The authors would like to thank Dr Lin Zou and Dr Cui Song (Center of Clinical Molecular Medicine, Children's Hospital of Chongqing Medical University; Chongqing, China) for case collection. The present study was supported by the National Natural Science Foundation of China (grant no. 30771202).

 Abbreviations α-satDNA

α-satellite DNA

 CENP-B

centromere protein B

 Chr21

chromosome 21

 DS

Down syndrome

 HAC

human artificial chromosome

 PCR

polymerase chain reaction

 References ShottSRJosephAHeithausDHearing loss in children with Down syndromeInt J Pediatr Otorhinolaryngol61199205200110.1016/S0165-5876(01)00572-911700189 NespoliLBurgioGRUgazioAGMaccarioRImmunological features of Down's syndrome: A reviewJ Intellect Disabil Res37543551199310.1111/j.1365-2788.1993.tb00324.x8124000 KarlssonBGustafssonJHedovGIvarssonSAAnnerénGThyroid dysfunction in Down's syndrome: Relation to age and thyroid autoimmunityArch Dis Child79242245199810.1136/adc.79.3.24298750201717691 WittmannTHymanADesaiAThe spindle: A dynamic assembly of microtubules and motorsNat Cell Biol3E28E34200110.1038/3505066911146647 WalczakCEHealdRMechanisms of mitotic spindle assembly and functionInt Rev Cytol265111158200810.1016/S0074-7696(07)65003-718275887 OhzekiJNakanoMOkadaTMasumotoHCENP-B box is required for de novo centromere chromatin assembly on human alphoid DNAJ Cell Biol159765775200210.1083/jcb.200207112124609872173396 TrowellHENagyAVisselBChooKHLong-range analyses of the centromeric regions of human chromosomes 13, 14 and 21: Identification of a narrow domain containing two key centromeric DNA elementsHum Mol Genet216391649199310.1093/hmg/2.10.16398268917 OkadaTOhzekiJNakanoMYodaKBrinkleyWRLarionovVMasumotoHCENP-B controls centromere formation depending on the chromatin contextCell13112871300200710.1016/j.cell.2007.10.04518160038 TanakaYTachiwanaHYodaKMasumotoHOkazakiTKurumizakaHYokoyamaSHuman centromere protein B induces translational positioning of nucleosomes on alpha-satellite sequencesJ Biol Chem2804160941618200510.1074/jbc.M50966620016183641 HassonDPanchenkoTSalimianKJSalmanMUSekulicNAlonsoAWarburtonPEBlackBEThe octamer is the major form of CENP-A nucleosomes at human centromeresNat Struct Mol Biol20687695201310.1038/nsmb.2562236445963760417 OkamotoYNakanoMOhzekiJLarionovVMasumotoHA minimal CENP-A core is required for nucleation and maintenance of a functional human centromereEMBO J2612791291200710.1038/sj.emboj.7601584173181871817632 IkenoMMasumotoHOkazakiTDistribution of CENP-B boxes reflected in CREST centromere antigenic sites on long-range alpha-satellite DNA arrays of human chromosome 21Hum Mol Genet312451257199410.1093/hmg/3.8.12457987298 AlkanCVenturaMArchidiaconoNRocchiMSahinalpSCEichlerEEOrganization and evolution of primate centromeric DNA from whole-genome shotgun sequence dataPLoS Comput Biol318071820200710.1371/journal.pcbi.003018117907796 BasuJStrombergGCompitelloGWillardHFVan BokkelenGRapid creation of BAC-based human artificial chromosome vectors by transposition with synthetic alpha-satellite arraysNucleic Acids Res33587596200510.1093/nar/gki20715673719548352 EarnshawWCSullivanKFMachlinPSCookeCAKaiserDAPollardTDRothfieldNFClevelandDWMolecular cloning of cDNA for CENP-B, the major human centromere autoantigenJ Cell Biol104817829198710.1083/jcb.104.4.81724357392114438 MasumotoHMasukataHMuroYNozakiNOkazakiTA human centromere antigen (CENP-B) interacts with a short specific sequence in alphoid DNA, a human centromeric satelliteJ Cell Biol10919631973198910.1083/jcb.109.5.196328085152115871 TanakaYKurumizakaHYokoyamaSCpG methylation of the CENP-B box reduces human CENP-B bindingFEBS J272282289200510.1111/j.1432-1033.2004.04406.x15634350 XiaYYDingYBLiuXQChenXMChengSQLiLBMaMFHeJLWangYXAllelic methylation status of CpG islands on chromosome 21q in patients with Trisomy 21Mol Med Rep916811688201424573226 UgarkovićDPlohlMVariation in satellite DNA profile-causes and effectsEMBO J2159555959200210.1093/emboj/cdf61212426367137204 SullivanLLBoivinCDMravinacBSongIYSullivanBAGenomic size of CENP-A domain is proportional to total alpha satellite array size at human centromeres and expands in cancer cellsChromosome Res19457470201110.1007/s10577-011-9208-5214844473565466 IrvineDVAmorDJPerryJSirventNPedeutourFChooKHSafferyRChromosome size and origin as determinants of the level of CENP-A incorporation into human centromeresChromosome Res12805815200410.1007/s10577-005-5377-415702419 MeštrovićNPavlekMCarACastagnone-SerenoPAbadPPlohlMConserved DNA motifs, including the CENP-B box-like, are possible promoters of satellite DNA array rearrangements in nematodesPLoS One8e67328201310.1371/journal.pone.0067328238262693694981 FachinettiDFolcoHDNechemia-ArbelyYValenteLPNguyenKWongAJZhuQHollandAJDesaiAJansenLEClevelandDWA two-step mechanism for epigenetic specification of centromere identity and functionNat Cell Biol1510561066201310.1038/ncb2805238731484418506 XiaYYDingYBLiuXQChenXMChengSQLiLBMaMFHeJLWangYXRacial/ethnic disparities in human DNA methylationBiochim Biophys Acta1846258262201425016140

Configuration of the chromosome 21 centromere and the nucleotide sequences of CENP-B boxes. (A) The arrows indicate 11-monomer repeating units; the black arrows indicate 171 bp monomers with a functional CENP-B box. The black bold line with two dash lines refers to sequencing area in α-satellite DNA. (B) The 17 bp motif of the CENP-B box. The nucleotide sequences in frames are required for CENP-B binding activity. CENP-B, centromere protein B.

PCR fragments of α-satellite DNA in DS and healthy control children. The (A) 773 bp and (B) 535 bp products contain two CENP-B boxes. Marker: DL2000. DS, Down syndrome; PCR, polymerase chain reaction.

Chromatograms of the four CENP-B boxes. The g.493_509, g.835_851, g.1173_1189 and g.1511_1527 sites of CENP-B boxes in (A) DS patients and (B) healthy children.

Chromatograms of six mutation sites in α-satellite DNA including g.661delC, g.670T>G, g.1239A>T, g.1343T>C, g.1035_1036insA and g.1076_1077insC. Mutation sites are indicated by black arrows.

Chromatograms of eight heterozygous sites in α-satellite DNA including g.525C/G, g.601T/C, g.727C/T, g.863A/C, g.1264C/G, g.1279A/G, g.1294C/T and g.1302 G/T. Mutation sites are indicated by black arrows.

Spectrum of α-satDNA variants detected in DS and control children.

Mutation characteristics DS (n=127) Control (n=100) P-value
g.661delC 127 (100%) 100 (100%) 0.904
g.670T>G 127 (100%) 100 (100%) 0.904
g.1239A>T 124 (97.6%) 100 (100%) 0.122
g.1343T>C 124 (97.6%) 100 (100%) 0.122
g.1035_1036insA 125 (98.4%) 97 (97%) 0.468
g.1076_1077insC 125 (98.4%) 97 (97%) 0.468
g.525C/G 125 (98.4%) 91 (91%) 0.01a
g.601T/C 93 (73.2%) 100 (100%) 0.00000002a
g.727C/T 120 (94.5%) 97 (97%) 0.36
g.863A/C 125 (98.4%) 100 (100%) 0.207
g.1264C/G 123 (96.9%) 100 (100%) 0.073
g.1279A/G 101 (79.5%) 94 (94%) 0.002a
g.1294C/T 105 (82.7%) 97 (97%) 0.0006a
g.1302G/T 103 (81.1%) 94 (94%) 0.004a

P<0.05 vs. control. α-satDNA, α-satellite DNA; DS, Down syndrome.